Chemical Compound

N1-Losartanyl-losartan

CAS Registry Number 230971-71-8
N1-Losartanyl-losartan chemical structure
Primary Record

N1-Losartanyl-losartan

In stock
7,998 g
Purity
99.5 %
CAS
230971-71-8

Compound Identifiers & Properties

CAS
230971-71-8
PubChem CID
71587661
SMILES
CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CN5C(=NN=N5)C6=CC=CC=C6C7=CC=C(C=C7)CN8C(=NC(=C8CO)Cl)CCCC)Cl
Canonical SMILES
CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnnn2Cc2c(Cl)nc(CCCC)n2Cc2ccc(-c3ccccc3-c3nn[nH]n3)cc2)cc1

Names & Synonyms

  • N1-Losartanyl-losartan
  • Losartan Impurity L
  • N1-Losartanyl-losartan (Losartan Impurity)
  • Losartan impurity
  • Losartan EP Impurity L
  • 230971-71-8
  • 06EYE5U7VX
  • UNII-06EYE5U7VX
  • RefChem:164313
  • N-LOSARTANYL-LOSARTAN
  • Losartan Potassium Impurity L
  • N2-LOSARTANYL-LOSARTAN
  • DTXSID60177666
  • C44H44Cl2N12O
  • SCHEMBL25777460
  • DTXCID20100157
  • MFCD27978054
  • ZINC94307056
  • IL24947
  • IL24948
  • Losartan potassium specified impurity L
  • Losartan potassium specified impurity L [EP]
  • N1-Losartanyl-losartan(LosartanImpurity)
  • FT-0670864
  • J1.095.551C
  • LOSARTAN POTASSIUM IMPURITY L [EP IMPURITY]
  • G91035
  • A899537
  • LOSARTAN POTASSIUM IMPURITY L (EP IMPURITY)
  • Q27236201
  • B0178-262459
  • (2-Butyl-1-((2'-(1-((2-butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazol-5-yl)methyl)-1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-4-chloro-1H-imidazol-5-yl)methanol
  • 1H-Imidazole-5-methanol, 2-butyl-1-((2'-(1-((2-butyl-4-chloro-1-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-imidazol-5-yl)methyl)-1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-4-chloro-
  • [2-butyl-3-[[4-[2-[1-[[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methyl]tetrazol-5-yl]phenyl]phenyl]methyl]-5-chloroimidazol-4-yl]methanol
  • 2-Butyl-1-[[2'-[1-[[2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazol-5-yl]methyl]-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-4-chloro-1H-imidazole-5-methanol
  • [2-Butyl-1-[[2'-[1-[[2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-5-yl]methyl]-1H-tetrazol-5-yl]biphenyl-4-yl]methyl-4-chloro-1H-imidazol-5-yl]methanol
  • [2-butyl-3-[[4-[2-[1-[[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methyl]tetrazol-5-yl]phenyl]phenyl]methyl]-5-chloro-imidazol-4-yl]methanol
  • {2-butyl-1-[(2'-{1-[(2-butyl-4-chloro-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methyl]-1H-1,2,3,4-tetrazol-5-yl}-[1,1'-biphenyl]-4-yl)methyl]-4-chloro-1H-imidazol-5-yl}methanol
  • {2-Butyl-1-[(2'-{1-[(2-butyl-4-chloro-1-{[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methyl]-1H-tetrazol-5-yl}[1,1'-biphenyl]-4-yl)methyl]-4-chloro-1H-imidazol-5-yl}methanol
  • 2-Butyl-1-[[2'-[1-[[2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazol-5-yl]methyl]-1H-tetrazol-5-yl ][1,1'-biphenyl]-4-yl]methyl]-4-chloro-1H-imidazole-5-methanol
  • 2-Butyl-1-[[2'-[1-[[2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazol-5-yl]methyl]-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-4-chloro-1H-imidazole-5-methanol; [2-Butyl-1-[[2'-[1-[[2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-5-yl]methyl]-1H-tetrazol-5-yl]biphenyl-4-yl]methyl-4-chloro-1H-imidazol-5-yl]methanol; Losartan Potassium Imp L (EP)
  • 2-Butyl-1-[[2'-[2-[[2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazol-5-yl]methyl]-2H-tetrazol-5-yl ][1,1'-biphenyl]-4-yl]methyl]-4-chloro-1H-imidazole-5-methanol
  • 2-Butyl-5-chloro-3-[[2 -[1-[[2-butyl-5-chloro-3-[[2 -(1H-tetrazole-5-yl)-1,1 -biphenyl-4-yl]methyl]-3H-imidazole-4-yl]methyl]-1H-tetrazole-5-yl]-1,1 -biphenyl-4-yl]methyl]-3H-imidazole-4-methanol
  • 230971-72-9